1.Inflammasomes in cancer: a double-edged sword.
Ryan KOLB ; Guang-Hui LIU ; Ann M JANOWSKI ; Fayyaz S SUTTERWALA ; Weizhou ZHANG
Protein & Cell 2014;5(1):12-20
Chronic inflammatory responses have long been observed to be associated with various types of cancer and play decisive roles at different stages of cancer development. Inflammasomes, which are potent inducers of interleukin (IL)-1β and IL-18 during inflammation, are large protein complexes typically consisting of a Nod-like receptor (NLR), the adapter protein ASC, and Caspase-1. During malignant transformation or cancer therapy, the inflammasomes are postulated to become activated in response to danger signals arising from the tumors or from therapy-induced damage to the tumor or healthy tissue. The activation of inflammasomes plays diverse and sometimes contrasting roles in cancer promotion and therapy depending on the specific context. Here we summarize the role of different inflammasome complexes in cancer progression and therapy. Inflammasome components and pathways may provide novel targets to treat certain types of cancer; however, using such agents should be cautiously evaluated due to the complex roles that inflammasomes and pro-inflammatory cytokines play in immunity.
Animals
;
Carcinoma
;
immunology
;
pathology
;
therapy
;
Gastrointestinal Neoplasms
;
immunology
;
pathology
;
therapy
;
Humans
;
Inflammasomes
;
metabolism
;
Melanoma
;
immunology
;
pathology
;
therapy
;
Neoplasms
;
immunology
;
pathology
;
therapy
;
Skin Neoplasms
;
immunology
;
pathology
;
therapy
2.Multiple lymphomatous polyposis of the gastrointestinal tract: a report of two cases with immunohistochemical studies.
Ju Hie LEE ; So Yeon YU ; Mun Ho YANG ; Lin CHANG ; Young Tae KO
Journal of Korean Medical Science 1992;7(2):173-178
We describe two cases of multiple lymphomatous polyposis in the gastrointestinal tract from the esophagus to the rectum. Clinical findings, histopathologic and immunohistochemical findings in paraffin embedded tissue are discussed. It is important to recognize this rare form of gastrointestinal lymphoma because of the prognostic and therapeutic implications.
Antigens, CD/analysis
;
Gastrointestinal Neoplasms/immunology/*pathology
;
Humans
;
Immunohistochemistry
;
Intestinal Polyps/immunology/*pathology
;
Lymphoma/immunology/*pathology
;
Male
;
Middle Aged
;
Polyps/immunology/*pathology
4.Plexiform fibromyxoma of stomach: a distinctive benign tumor of gastric antrum.
Feng-hua WANG ; Zheng-rong CHEN ; Hui-lin NIU ; Rong-xin ZENG ; Jian-qing XIA
Chinese Journal of Pathology 2012;41(3):190-191
Actins
;
immunology
;
metabolism
;
Antibodies, Monoclonal
;
metabolism
;
Child
;
Diagnosis, Differential
;
Fibroma
;
metabolism
;
pathology
;
surgery
;
Follow-Up Studies
;
Gastrointestinal Neoplasms
;
metabolism
;
pathology
;
Gastrointestinal Stromal Tumors
;
metabolism
;
pathology
;
Humans
;
Leiomyoma
;
metabolism
;
pathology
;
Male
;
Pyloric Antrum
;
pathology
;
Stomach Neoplasms
;
metabolism
;
pathology
;
surgery
;
Vimentin
;
metabolism
5.Histological and immunohistochemical studies on primary gastrointestinal lymphomas.
Jung Dal LEE ; Young Hyeh KO ; Jeong Hee PARK ; Kyung Rang MIN ; Kyung Nam PARK
Journal of Korean Medical Science 1993;8(1):17-23
To study the characteristics and histogenesis of the malignant lymphomas derived from the gastrointestinal mucosa, histologic and immunohistochemical analyses were performed on a series of 28 malignant lymphomas of the gastrointestinal tract. By cytomorphologic classification, there were two small lymphocytic lymphomas, one small cleaved cell lymphoma, two mixed small cleaved and large cell lymphomas, 17 large cell lymphomas, one small noncleaved cell lymphoma, three immunoblastic lymphomas, and two lymphoblastic lymphomas. This distribution of histologic types was compatible with that of nodal lymphoma. The lymphomas with poor prognostic histology (23 cases) outnumbered those with favorable prognosis (five cases). Three of 28 cases (one in the stomach and two in the small intestine) had cytologic features consistent with centrocytoid cell lymphoma of the mucosa associated lymphoid tissue and were large cell lymphomas. Immunophenotypically, 23 cases expressed B-cell markers (82.1%) and three cases reacted with T-cell markers. Two cases did not react with either T-cell or B-cell markers. True histiocytic lymphomas were not identified. Gastric lymphomas (nine cases) and colorectal lymphomas (three cases) were of B-lymphocyte origin whereas T-cell lymphomas were noted in the small intestine (two cases) and ileocecal region (one case). Three cases of centrocytoid lymphoma were of B-lymphocyte origin. Histologically B-cell lineage lymphomas were evenly distributed on various histologic subtypes but all T-lineage lymphomas belonged to the large cell type. The two cases with undetermined phenotype were lymphoblastic lymphomas histologically. This study showed that the primary GIT lymphomas, mostly of B-cell lineage, were not cytomorphologically distinctive from the nodal lymphomas.(ABSTRACT TRUNCATED AT 250 WORDS)
Adolescent
;
Adult
;
Aged
;
Aged, 80 and over
;
Child
;
Female
;
Gastrointestinal Neoplasms/classification/immunology/*pathology
;
Humans
;
Immunohistochemistry
;
Lymphoma/classification/immunology/*pathology
;
Male
;
Middle Aged
6.Utility of Thyroid Transcription Factor-1 and Cytokeratin 20 in Identifying the Origin of Metastatic Carcinomas of Cervical Lymph Nodes.
Journal of Korean Medical Science 2002;17(4):512-517
The identification of primary location of a metastatic tumor is a difficult diagnostic problem and sometimes can be facilitated by the use of immunohistochemical markers. Thyroid transcription factor-1 (TTF-1) is a 38-kDa nuclear homeodomain transcription factor that is expressed specifically in lung or thyroid neoplasms. Cytokeratin 20 (CK20) is a 46-kDa low-molecular-weight cytokeratin that shows restricted expression in adenocarcinomas of the gastrointestinal tract (GIT) and transitional cell carcinomas of the urinary tract. We studied the immunohistochemical expression of TTF-1 and CK20 in 68 metastatic carcinomas in cervical lymph nodes. The primary sites were the lung in 29 cases, stomach in 13, colorectum in 3, and other sites in 23. TTF-1 expression was detected in 69.0% of metastatic lung carcinomas and none in metastatic GIT carcinomas, whereas CK20 expression was detected in 68.8% of metastatic GIT carcinomas and none of metastatic lung carcinomas. TTF-1 had a specificity of 0.95 and a sensitivity of 0.69 for metastatic lung carcinoma, whereas CK20 had a specificity of 1.00 and a sensitivity of 0.69 for metastatic GIT carcinoma. These results indicate that TTF-1 and CK20 should be the first choice as a component of antibody panel to prove or to exclude the lung and GIT origin, respectively, especially in patients presenting with metastatic carcinomas of unknown primary site.
Adenocarcinoma/chemistry/pathology/secondary
;
Carcinoma/chemistry/pathology/*secondary
;
Gastrointestinal Neoplasms/chemistry/pathology
;
Homeodomain Proteins/analysis
;
Humans
;
Intermediate Filament Proteins/*analysis/immunology
;
Keratin-20
;
Lung Neoplasms/chemistry/pathology
;
Lymph Nodes/chemistry/pathology
;
Lymphatic Metastasis/*diagnosis/pathology
;
Neck
;
Neoplasms, Unknown Primary/chemistry/pathology
;
Nuclear Proteins/*analysis/immunology
;
Sensitivity and Specificity
;
Transcription Factors/*analysis/immunology
;
Tumor Markers, Biological/analysis
7.Introduction of WHO classification of tumours of soft tissue, the fourth edition.
Chinese Journal of Pathology 2013;42(6):363-365
Classification
;
methods
;
Dermatofibrosarcoma
;
classification
;
pathology
;
Gastrointestinal Stromal Tumors
;
immunology
;
pathology
;
Hemangioendothelioma
;
classification
;
metabolism
;
pathology
;
Humans
;
Neoplasms, Connective and Soft Tissue
;
classification
;
metabolism
;
pathology
;
Neurilemmoma
;
pathology
;
Rhabdomyosarcoma
;
metabolism
;
pathology
;
Sclerosis
;
World Health Organization
8.Detection of Malignant Cells in Pleural Fluid or Ascites by CD44v8-10/CD44v10 competitive RT-PCR.
Myung Ju AHN ; Yun Hee NOH ; Ho Ju YOON ; Suck Cheol YANG ; Jang Won SOHN ; Jung Hae CHOI ; Young Yeul LEE ; Il Young CHOI ; In Soon KIM ; Yong Sung LEE ; Chan Kum PARK
The Korean Journal of Internal Medicine 2001;16(1):30-35
BACKGROUND: CD44 is a cell surface adhesion molecule which has been implicated in various biologic functions as lymphocyte homing and activation, cellular migration and extracellular matrix adhesion. Over-expression of CD44v8- 10 has been found in several cancers and is considered to be associated with tumor progression and metastasis. Recently, a novel molecular method, CD44v8- 10/CD44v10 competitive reverse transcription-polymerase chain reaction(RT-PCR) has been developed for detecting cancer cells over-expressing CD44v8-10. METHODS: We analyzed from benign and malignant pleural effusion and ascites by CD44 competitive RT-PCR and compared to the conventional cytology. RESULTS: The CD44 competitive RT-PCR analysis showed that all the 24 samples associated with benign disease presented a predominant expression of the CD44v10 transcript (v8-10/v10 ratio: 0.126-0.948), whereas 6 of 7 malignant pleural samples associated with cytology positive cancer expressed the CD44v8-10 transcript (v8-10/v10 ratio > 1.00). CONCLUSION: These results indicate that CD44 competitive RT-PCR assay is a useful and adjunct to cytological examination in cancer diagnosis, especially in detecting exfoliated cancer cells in pleural effusion.
Adult
;
Aged
;
Aged, 80 and over
;
Antigens, CD44/analysis*
;
Ascites/pathology*
;
Ascites/immunology*
;
Base Sequence
;
Carcinoma, Non-Small-Cell Lung/pathology
;
Carcinoma, Non-Small-Cell Lung/immunology
;
Comparative Study
;
Female
;
Gastrointestinal Neoplasms/pathology
;
Gastrointestinal Neoplasms/immunology
;
Human
;
Lung Neoplasms/pathology
;
Lung Neoplasms/chemistry
;
Male
;
Middle Age
;
Molecular Sequence Data
;
Pleural Effusion, Malignant/pathology*
;
Pleural Effusion, Malignant/chemistry*
;
Reverse Transcriptase Polymerase Chain Reaction*
;
Sensitivity and Specificity
;
Support, Non-U.S. Gov't
9.Extramedullary relapse of multiple myeloma presenting as massive upper gastrointestinal bleeding: a rare complication.
Bulent YASAR ; Pembegul GUNES ; Ozgur GULER ; Selma YAGCI ; Dilek BENEK
The Korean Journal of Internal Medicine 2015;30(4):538-539
No abstract available.
Aged
;
Antigens, CD38/analysis
;
Biomarkers, Tumor/analysis
;
Biopsy
;
Gastrointestinal Hemorrhage/diagnosis/*etiology/therapy
;
Gastroscopy
;
Hematemesis/etiology
;
Humans
;
Immunohistochemistry
;
Male
;
Melena/etiology
;
Membrane Glycoproteins/analysis
;
Multiple Myeloma/*complications/immunology/pathology/therapy
;
Recurrence
;
Stomach Neoplasms/*complications/immunology/pathology/therapy
10.Hepatic epithelioid angiomyolipoma: a clinicopathologic analysis of 25 cases.
Huan XU ; Huan WANG ; Xiuhui ZHANG ; Gandi LI
Chinese Journal of Pathology 2014;43(10):685-689
OBJECTIVETo study the clinicopathologic features, immunophenotype, histological diagnosis and prognosis of hepatic epithelioid angiomyolipoma.
METHODSClinical data of 25 cases of hepatic epithelioid angiomyolipoma were collected along with follow-up study of the patients. The pathological features were documented and immunohistochemical study of various markers was performed with an emphasis on diagnosis and differential diagnosis.
RESULTSHepatic epithelioid angiomyolipoma was more commonly found in young women without characteristic clinical symptoms. Its morphological features were characterized by marked cytological atypia, relatively rare mitotic figures; radial distribution of tumor cells around the thin-walled blood vessels or muscular vessels; and the presence of common multinucleated giant cells and large ganglion-like tumor cells. The tumor cells expressed both melanoma cell markers (HMB45, MART-1) and smooth muscle cell markers (SMA). Tumor cells expressed various other markers including ER 16% (4/25), PR 32% (8/25), TFE3 24% (6/25) and p53 60% (15/25).
CONCLUSIONSHepatic epithelioid angiomyolipoma has variable morphological features and characteristic immunohistochemical phenotype. The differential diagnoses include a variety of tumors. The biological behavior of the tumor tends to be benign.
Age Factors ; Angiomyolipoma ; genetics ; immunology ; metabolism ; pathology ; Biomarkers, Tumor ; metabolism ; Diagnosis, Differential ; Female ; Follow-Up Studies ; Gastrointestinal Neoplasms ; Giant Cells ; pathology ; Humans ; Immunohistochemistry ; Immunophenotyping ; Liver Neoplasms ; genetics ; immunology ; metabolism ; pathology ; MART-1 Antigen ; metabolism ; Melanoma-Specific Antigens ; metabolism ; Muscle, Smooth ; metabolism ; Prognosis